The increased expression of ANGPTL4 observed in tumor cells at the invasive front in the overweight/obese group now provides novel in vivo evidence supporting a role for ANGPTL4 in obesity-related breast cancer. This evidence concerns the gene ANGPTL4 and neoplasm.